The recommendations come at a time when treatments for chronic lymphocytic leukemia (CLL), such as venetoclax, are making deep remissions and undetectable minimal residual disease (MRD) after a fixed ...
Test detects genetic abnormalities to aid in the prediction of chronic lymphocytic leukemia patient survival. Abbott received 510k clearance for an in vitro diagnostic test to aid in determining the ...
Transcript: Nicole Lamanna, M.D.: When somebody does need therapy, obviously there are a few tests that typically are run prior to initiating therapy. Oftentimes a lot of bloodwork will be drawn, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results